Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
195.77
+1.58 (0.81%)
Nov 22, 2024, 4:00 PM EST - Market closed
CRL Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 25, 2021 | Dec '20 Dec 26, 2020 | Dec '19 Dec 28, 2019 | 2018 - 2014 |
| Net Income | 423.78 | 474.62 | 486.23 | 390.98 | 364.3 | 252.02 | Upgrade
|
| Depreciation & Amortization | 340.15 | 314.12 | 303.87 | 265.54 | 234.92 | 198.1 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.63 | 0.96 | -123.41 | -25.03 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 33.05 | 41.91 | 5.82 | 0.73 | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | -115.86 | -97.83 | 26.78 | 30.42 | -100.86 | -20.71 | Upgrade
|
| Stock-Based Compensation | 72.18 | 72.05 | 73.62 | 71.47 | 56.34 | 57.27 | Upgrade
|
| Provision & Write-off of Bad Debts | 15.42 | 18.23 | 6.71 | 1.66 | 6.38 | - | Upgrade
|
| Other Operating Activities | -23.64 | -37.79 | -7.41 | -17.92 | 11.77 | -11.92 | Upgrade
|
| Change in Accounts Receivable | 43.95 | -33.43 | -150.57 | -26.63 | -85.63 | -8.32 | Upgrade
|
| Change in Inventory | -4.39 | -62.3 | -78.52 | -25.16 | -18.38 | -21.4 | Upgrade
|
| Change in Accounts Payable | -0.99 | -20.43 | -2.65 | 44.9 | 0.75 | 29.78 | Upgrade
|
| Change in Unearned Revenue | 22.51 | -37.31 | 88.12 | 3.52 | 37.6 | -14.52 | Upgrade
|
| Change in Other Net Operating Assets | -10.63 | 51.09 | -8.92 | 46.31 | 39.38 | 20.64 | Upgrade
|
| Operating Cash Flow | 796.16 | 683.9 | 619.64 | 760.8 | 546.58 | 480.94 | Upgrade
|
| Operating Cash Flow Growth | 14.11% | 10.37% | -18.55% | 39.19% | 13.65% | 9.95% | Upgrade
|
| Capital Expenditures | -235.67 | -318.53 | -324.73 | -228.77 | -166.56 | -140.51 | Upgrade
|
| Cash Acquisitions | -150.1 | -194.79 | -283.39 | -1,293 | -418.63 | -515.7 | Upgrade
|
| Divestitures | - | - | 163.28 | 122.69 | - | - | Upgrade
|
| Investment in Securities | -20.97 | -47.55 | -153.73 | -39.02 | -15.29 | -21.4 | Upgrade
|
| Other Investing Activities | -0.61 | -2.29 | -9.35 | 0.26 | -1.07 | -3.89 | Upgrade
|
| Investing Cash Flow | -407.35 | -563.16 | -607.92 | -1,438 | -601.54 | -681.5 | Upgrade
|
| Long-Term Debt Issued | - | 776.35 | 2,952 | 6,951 | 2,231 | 3,358 | Upgrade
|
| Long-Term Debt Repaid | - | -851.68 | -2,933 | -6,243 | -2,200 | -3,125 | Upgrade
|
| Net Debt Issued (Repaid) | -217.66 | -75.32 | 19.79 | 708.24 | 30.59 | 233.87 | Upgrade
|
| Issuance of Common Stock | 29.05 | 25.6 | 25.11 | 45.65 | 46.59 | 34.55 | Upgrade
|
| Repurchase of Common Stock | -119.19 | -24.16 | -38.65 | -40.71 | -23.98 | -18.09 | Upgrade
|
| Other Financing Activities | -43.68 | -11.64 | -48.65 | -40.58 | -5.95 | -18.4 | Upgrade
|
| Financing Cash Flow | -351.48 | -85.52 | -42.4 | 672.6 | 47.25 | 231.94 | Upgrade
|
| Foreign Exchange Rate Adjustments | 8.7 | 8.04 | 25.58 | 17.73 | 0.79 | 11.36 | Upgrade
|
| Net Cash Flow | 46.02 | 43.27 | -5.1 | 13.2 | -6.93 | 42.73 | Upgrade
|
| Free Cash Flow | 560.48 | 365.37 | 294.91 | 532.03 | 380.02 | 340.42 | Upgrade
|
| Free Cash Flow Growth | 52.11% | 23.89% | -44.57% | 40.00% | 11.63% | 14.48% | Upgrade
|
| Free Cash Flow Margin | 13.80% | 8.85% | 7.42% | 15.03% | 13.00% | 12.99% | Upgrade
|
| Free Cash Flow Per Share | 10.86 | 7.10 | 5.75 | 10.35 | 7.51 | 6.85 | Upgrade
|
| Cash Interest Paid | 124.66 | 132.1 | 100.75 | 70.78 | 72.46 | 67.81 | Upgrade
|
| Cash Income Tax Paid | 109.2 | 90.37 | 75.91 | 75.44 | 60.06 | 54.06 | Upgrade
|
| Levered Free Cash Flow | 495.27 | 218.76 | 304.27 | 629.6 | 269.38 | 362.79 | Upgrade
|
| Unlevered Free Cash Flow | 577.52 | 304.2 | 341.32 | 675.8 | 323.4 | 400.84 | Upgrade
|
| Change in Net Working Capital | -20.48 | 173.55 | 127.98 | -171.06 | 75.73 | -43.61 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.